162 related articles for article (PubMed ID: 14555220)
1. The prodigiosins, proapoptotic drugs with anticancer properties.
Pérez-Tomás R; Montaner B; Llagostera E; Soto-Cerrato V
Biochem Pharmacol; 2003 Oct; 66(8):1447-52. PubMed ID: 14555220
[TBL] [Abstract][Full Text] [Related]
2. The prodigiosins: a new family of anticancer drugs.
Montaner B; Pérez-Tomás R
Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
[TBL] [Abstract][Full Text] [Related]
3. Development of natural anti-tumor drugs by microorganisms.
Chang CC; Chen WC; Ho TF; Wu HS; Wei YH
J Biosci Bioeng; 2011 May; 111(5):501-11. PubMed ID: 21277252
[TBL] [Abstract][Full Text] [Related]
4. Prodigiosins as anti cancer agents: living upto their name.
Pandey R; Chander R; Sainis KB
Curr Pharm Des; 2009; 15(7):732-41. PubMed ID: 19275639
[TBL] [Abstract][Full Text] [Related]
5. New insights on the antitumoral properties of prodiginines.
Pérez-Tomás R; Viñas M
Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunosuppressive activity of novel prodigiosin derivatives.
D'Alessio R; Bargiotti A; Carlini O; Colotta F; Ferrari M; Gnocchi P; Isetta A; Mongelli N; Motta P; Rossi A; Rossi M; Tibolla M; Vanotti E
J Med Chem; 2000 Jun; 43(13):2557-65. PubMed ID: 10891115
[TBL] [Abstract][Full Text] [Related]
8. Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome.
Liu P; Wang YY; Qi X; Gu Q; Geng M; Li J
PLoS One; 2013; 8(6):e65381. PubMed ID: 23799011
[TBL] [Abstract][Full Text] [Related]
9. Prodigiosin and its potential applications.
Darshan N; Manonmani HK
J Food Sci Technol; 2015 Sep; 52(9):5393-407. PubMed ID: 26344956
[TBL] [Abstract][Full Text] [Related]
10. Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells.
Pérez-Tomás R; Montaner B
Histol Histopathol; 2003 Apr; 18(2):379-85. PubMed ID: 12647787
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by gamma-proteobacterium, using stratum corneum epidermis of the Yucatan micropig.
Nakashima T; Kato Y; Yamaguchi K; Oda T
J Infect Chemother; 2005 Jun; 11(3):123-8. PubMed ID: 15990975
[TBL] [Abstract][Full Text] [Related]
12. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin.
Montaner B; Castillo-Avila W; Martinell M; Ollinger R; Aymami J; Giralt E; Pérez-Tomás R
Toxicol Sci; 2005 Jun; 85(2):870-9. PubMed ID: 15788728
[TBL] [Abstract][Full Text] [Related]
13. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
Soto-Cerrato V; Llagostera E; Montaner B; Scheffer GL; Perez-Tomas R
Biochem Pharmacol; 2004 Oct; 68(7):1345-52. PubMed ID: 15345324
[TBL] [Abstract][Full Text] [Related]
15. Properties and applications of undecylprodigiosin and other bacterial prodigiosins.
Stankovic N; Senerovic L; Ilic-Tomic T; Vasiljevic B; Nikodinovic-Runic J
Appl Microbiol Biotechnol; 2014 May; 98(9):3841-58. PubMed ID: 24562326
[TBL] [Abstract][Full Text] [Related]
16. Biological Potential and Mechanism of Prodigiosin from
Li D; Liu J; Wang X; Kong D; Du W; Li H; Hse CY; Shupe T; Zhou D; Zhao K
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400387
[TBL] [Abstract][Full Text] [Related]
17. Anticancer and immunosuppressive properties of bacterial prodiginines.
Williamson NR; Fineran PC; Gristwood T; Chawrai SR; Leeper FJ; Salmond GP
Future Microbiol; 2007 Dec; 2(6):605-18. PubMed ID: 18041902
[TBL] [Abstract][Full Text] [Related]
18. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.
Ohkuma S; Sato T; Okamoto M; Matsuya H; Arai K; Kataoka T; Nagai K; Wasserman HH
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):731-41. PubMed ID: 9729483
[TBL] [Abstract][Full Text] [Related]
19. Anion transporters and biological systems.
Gale PA; Pérez-Tomás R; Quesada R
Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
[TBL] [Abstract][Full Text] [Related]
20. Non-apoptotic concentrations of prodigiosin (H+/Cl- symporter) inhibit the acidification of lysosomes and induce cell cycle blockage in colon cancer cells.
Castillo-Avila W; Abal M; Robine S; Pérez-Tomás R
Life Sci; 2005 Nov; 78(2):121-7. PubMed ID: 16126233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
